Meningococcal conjugate vaccine safety surveillance in the Vaccine Safety Datalink using a tree-temporal scan data mining method
- PMID: 29446176
- PMCID: PMC10878474
- DOI: 10.1002/pds.4397
Meningococcal conjugate vaccine safety surveillance in the Vaccine Safety Datalink using a tree-temporal scan data mining method
Abstract
Purpose: The objective of our study was to conduct a data mining analysis to identify potential adverse events (AEs) following MENACWY-D using the tree-temporal scan statistic in the Vaccine Safety Datalink population and demonstrate the feasibility of this method in a large distributed safety data setting.
Methods: Traditional pharmacovigilance techniques used in vaccine safety are generally geared to detecting AEs based on pre-defined sets of conditions or diagnoses. Using a newly developed tree-temporal scan statistic data mining method, we performed a pilot study to evaluate the safety profile of the meningococcal conjugate vaccine Menactra® (MenACWY-D), screening thousands of potential AE diagnoses and diagnosis groupings. The study cohort included enrolled participants in the Vaccine Safety Datalink aged 11 to 18 years who had received MenACWY-D vaccination(s) between 2005 and 2014. The tree-temporal scan statistic was employed to identify statistical associations (signals) of AEs following MENACWY-D at a 0.05 level of significance, adjusted for multiple testing.
Results: We detected signals for 2 groups of outcomes: diseases of the skin and subcutaneous tissue, fever, and urticaria. Both groups are known AEs following MENACWY-D vaccination. We also identified a statistical signal for pleurisy, but further examination suggested it was likely a false signal. No new MENACWY-D safety concerns were raised.
Conclusions: As a pilot study, we demonstrated that the tree-temporal scan statistic data mining method can be successfully applied to screen broadly for a wide range of vaccine-AE associations within a large health care data network.
Keywords: Bell's palsy; Menactra; adverse events; pharmacoepidemiology; post-licensure.
Copyright © 2018 John Wiley & Sons, Ltd.
Conflict of interest statement
CONFLICT OF INTEREST
None declared.
Figures
![FIGURE 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/10878474/bin/nihms-1964592-f0001.gif)
![FIGURE 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/10878474/bin/nihms-1964592-f0002.gif)
![FIGURE 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/10878474/bin/nihms-1964592-f0003.gif)
![FIGURE 4](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/10878474/bin/nihms-1964592-f0004.gif)
![FIGURE 5](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/10878474/bin/nihms-1964592-f0005.gif)
Similar articles
-
Post-licensure safety surveillance study of routine use of quadrivalent meningococcal diphtheria toxoid conjugate vaccine.Vaccine. 2017 Dec 14;35(49 Pt B):6879-6884. doi: 10.1016/j.vaccine.2017.09.032. Epub 2017 Sep 21. Vaccine. 2017. PMID: 28941623 Clinical Trial.
-
Adverse events following quadrivalent meningococcal diphtheria toxoid conjugate vaccine (Menactra®) reported to the Vaccine Adverse Event Reporting System (VAERS), 2005-2016.Vaccine. 2020 Sep 11;38(40):6291-6298. doi: 10.1016/j.vaccine.2020.07.039. Epub 2020 Jul 31. Vaccine. 2020. PMID: 32747215 Free PMC article. Review.
-
Drug safety data mining with a tree-based scan statistic.Pharmacoepidemiol Drug Saf. 2013 May;22(5):517-23. doi: 10.1002/pds.3423. Epub 2013 Mar 20. Pharmacoepidemiol Drug Saf. 2013. PMID: 23512870
-
Safety of a quadrivalent meningococcal serogroups A, C, W and Y conjugate vaccine (MenACWY-CRM) administered with routine infant vaccinations: results of an open-label, randomized, phase 3b controlled study in healthy infants.Vaccine. 2014 Feb 12;32(8):965-72. doi: 10.1016/j.vaccine.2013.12.034. Epub 2014 Jan 4. Vaccine. 2014. PMID: 24397906 Clinical Trial.
-
Clinical trial and postmarketing safety experience with MenACWY-TT, a meningococcal group A, C, W, and Y tetanus conjugate vaccine.Vaccine. 2022 Nov 22;40(49):7014-7021. doi: 10.1016/j.vaccine.2022.09.077. Epub 2022 Oct 22. Vaccine. 2022. PMID: 36283896 Review.
Cited by
-
Active surveillance for adverse events of influenza vaccine safety in elderly cancer patients using self-controlled tree-temporal scan statistic analysis.Sci Rep. 2023 Aug 16;13(1):13346. doi: 10.1038/s41598-023-40091-y. Sci Rep. 2023. PMID: 37587127 Free PMC article.
-
A broad assessment of covid-19 vaccine safety using tree-based data-mining in the vaccine safety datalink.Vaccine. 2023 Jan 16;41(3):826-835. doi: 10.1016/j.vaccine.2022.12.026. Epub 2022 Dec 16. Vaccine. 2023. PMID: 36535825 Free PMC article.
-
A Broad Safety Assessment of the Recombinant Herpes Zoster Vaccine.Am J Epidemiol. 2022 Mar 24;191(5):957-964. doi: 10.1093/aje/kwac030. Am J Epidemiol. 2022. PMID: 35152283 Free PMC article.
-
A novel data mining application to detect safety signals for newly approved medications in routine care of patients with diabetes.Endocrinol Diabetes Metab. 2021 Apr 6;4(3):e00237. doi: 10.1002/edm2.237. eCollection 2021 Jul. Endocrinol Diabetes Metab. 2021. PMID: 34277962 Free PMC article.
-
Health care professionals' preference for a fully liquid, ready-to-use hexavalent vaccine in Spain.Prev Med Rep. 2021 Apr 16;22:101376. doi: 10.1016/j.pmedr.2021.101376. eCollection 2021 Jun. Prev Med Rep. 2021. PMID: 33996389 Free PMC article.
References
-
- Martin D, Menschik D, Bryant-Genevier M, Ball R. Data mining for prospective early detection of safety signals in the vaccine adverse event reporting system (VAERS): a case study of febrile seizures after a 2010–2011 seasonal influenza virus vaccine. Drug Saf. 2013;36(7):547–556. - PubMed
-
- Niu MT, Erwin DE, Braun MM. Data mining in the US vaccine adverse event reporting system (VAERS): early detection of intussusception and other events after rotavirus vaccination. Vaccine. 2001;19(32):4627–4634. - PubMed
-
- DuMouchel W Bayesian data mining in large frequency tables, with application to the FDA spontaneous reporting system. Am. Stat 1999;53(3):177–190.
-
- Varricchio F, Iskander J, DeStefano F, et al. Understanding vaccine safety information from the vaccine adverse event reporting system. Pediatr Infect Dis J. 2004;23(4):287–294. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials